Publicaciones en colaboración con investigadoras/es de Universitat de les Illes Balears (41)

2023

  1. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay

    Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275

2021

  1. 5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1155-1163

  2. 5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

    World Journal of Biological Psychiatry, Vol. 22, Núm. 7, pp. 505-515

2020

  1. Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 270, Núm. 7, pp. 869-880

2019

  1. Optimization and pharmacological characterization of receptor-mediated Gi/o activation in postmortem human prefrontal cortex

    Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 6, pp. 649-659

2018

  1. Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay

    Purinergic Signalling, Vol. 14, Núm. 2, pp. 177-190

2017

  1. Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes

    Journal of Neural Transmission, Vol. 124, Núm. 9, pp. 1123-1133

2016

  1. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

2015

  1. Adenosine A1 receptors are selectively coupled to Gαi-3 in postmortem human brain cortex: Guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding/immunoprecipitation study

    European Journal of Pharmacology, Vol. 764, pp. 592-598

  2. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: Effect of psychotropic treatment

    Schizophrenia Research, Vol. 161, Núm. 2-3, pp. 446-451

2014

  1. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

    Neuroscience, Vol. 277, pp. 541-551

  2. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

2013

  1. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

    Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188

  2. Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders

    Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders (Springer New York), pp. 213-238

  3. Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: Basal contents and effects of psychotropic medications

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 3, pp. 683-689

2012

  1. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051

  2. Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: Down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 573-588

2011

  1. Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats

    Neuroscience, Vol. 196, pp. 1-15

  2. Noradrenergic system in depression

    Neurobiology of Depression (CRC Press), pp. 171-184

2010

  1. Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain

    Neurochemistry International, Vol. 57, Núm. 7, pp. 722-729